Ramucirumab for Carcinomas: A Journey to Unfold

Dear Dr. Renukaprasad A R, Are you aware of the recommended indications for ramucirumab? 2nd line advanced gastric cancer (GC)/gastroesophageal junction adenocarcinoma 1st line epidermal growth factor receptor mutation-positive (EGFRm+) metastatic non-small-cell lung cancer (NSCLC) 2nd line locally advanced or metastatic NSCLC 2nd line metastatic colorectal cancer 2nd line advanced or unresectable hepatocellular carcinoma Join the experts for a detailed discussion on managing EGFRm+ advanced NSCLC and GC with Ramucirumab, TODAY at 07:30 PM IST. We look forward to your active participation Highlights: Outline of ramucirumab's Journey in India Case study: Ramucirumab as second-line GC treatment Improve treatment options for EGFRm+ advanced NSCLC - RELAYing RELAY Join the Session   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Join Managing Endocrine Disorders Session

Dear Dr. Renukaprasad A R, Endocrine disorders, including diabetes mellitus and thyroid disorders, have complex pathophysiology and overlapping symptoms. Therefore, sound knowledge of different endocrine disorders and their diagnosis and management strategies helps physicians efficiently treat patients of different age groups. To know the latest developments in the management of endocrine disorders, join the expert endocrinologists and diabetologists in our exclusive webinar, TODAY, 3:00 PM IST onwards. Topics - Thyroid and Other Autoimmune Disorders in T1D - Dr. A G Unnikrishnan T2D and Double Diabetes in the Young - Dr. Radhika Purushothaman MODY: Genetics and Clinical Approach - Dr. V Mohan Click to Join   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

A Recent Update in Nano-ophthalmology

Docplexus - India's Largest Online Community of Verified Doctors

Hi Renukaprasad A R, Are you aware of the nanotechnology-based advancements in DED management? Artificial tears are the primary treatment option for DED because they help with symptomatic relief. However, conventional formulations have poor bioavailability due to the complex ophthalmic structure and rapid tear turnover. Nanotechnology has the solution to this limitation. Here is an article on the overview of nanotechnology with particular emphasis on its application in ophthalmology and DED. Highlights- A brief overview of nanotechnology Different types of nanosystems Introduction to lipid-based nanocarriers (LNCs) Applications of LNCs Know More If you don't want to receive these emails in the future, please unsubscribe.

What's New in Diabetic Foot Ulcer Management?

Docplexus - India's Largest Online Community of Verified Doctors

Hi Renukaprasad A R, Diabetic foot ulcers (DFU) are the most common complications in diabetic patients. DFUs present a significant financial burden and are associated with higher mortality risk. Implementing preventive measures is the best approach for managing DFUs.1 Read this latest issue of "Frontier in Diabetes" from Roche Diabetes for updates on diagnosis and management of DFU. Highlights of the newsletter- Strategies for early prevention of DFU development and its management An early marker of DFU Indian perspective on diagnosis and management of diabetic foot Importance of self-monitoring of blood glucose in patients with DFU Exclusive case study- False aneurysm in Charcot's foot Read More Reference: Dogruel H et al., World J Diabetes. 2022 Jan 15;13(1):27-36. If you don't want to receive these emails in the future, please unsubscribe.

Understanding Systemic Therapy for Renal Cell Carcinoma

Dear Dr. Renukaprasad A R, The preferred treatment for renal cell carcinoma has evolved over the years from cytokine-based therapy to immune-checkpoint inhibitors and combination therapy. Considering patient history, disease progression, and biochemical test results while designing the treatment strategy can greatly improve patient outcomes. Join us for an insightful session as Dr. Nikhil Krishna Haridas shares his expertise on "Systemic Therapy: Selecting First-line Therapy and Later-line Therapy", Today at 3:00 PM IST. Join the Session   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Advancing Artificial Tears’ Use for Improved Patient Outcomes

Docplexus - India's Largest Online Community of Verified Doctors

Current Treatment Options of DED in India: Bridging the Gap Hi Renukaprasad A R, What challenges do you, as eye care practitioners face in managing dry eye disease (DED)? What are your patients' biggest challenges while dealing with the treatment? Despite the accessibility of several treatment modalities, DED is still a prevalent and troublesome condition for patients and ophthalmologists alike. So is there a solution? Read this article to gain an insight into the everyday challenges of managing DED, how to overcome them, and the role of lipid-containing artificial tear products in relieving DED symptoms. Highlights: Prevalence of DED and challenges in its management The root cause of the gap between DED and its appropriate treatment Currently available treatment modalities in India for DED The role of lipid-containing artificial tears in DED and providing a better quality of life Read Article If you don't want to receive these emails in the future, please unsubscribe.

DED: Role of Physical Comorbidities

Dear Dr. Renukaprasad A R, Dry eye disease (DED), a common ocular surface disorder, results from the insufficient production of tears. It is a chronic multifactorial condition that leads to ocular discomfort, fatigue, visual disturbance, and, ultimately, reduced quality of life (QoL). Here is an Infographic that discusses how physical comorbidities influence DED and demonstrates its impact on the patient's physical, psychological and social functioning. Highlights: Impact of DED on vision related-QoL and psychological status Patient experience in DED Physical comorbidities and DED: Their association Impact of comorbidities on DED Click to View   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Guidance on Trans Axillary Aortic Valve Replacement

Dear Dr. Renukaprasad A R, Trans axillary Aortic Valve Replacement is performed under femorofemoral cardiopulmonary bypass using long-shafted minimally invasive instruments. The procedure requires easy vascular access to deliver the transcatheter valve to the aortic annulus. It is a minimally invasive method for treating aortic stenosis and has superior and well-established outcomes. Join Dr. S. Thiagarajamurthy for an exclusive Cardiac MasterSeries session on "Trans Axillary Aortic Valve Replacement" TODAY at 3:00 PM IST. Key points of discussion: Minimally Invasive Cardiac Surgery - AVR How to select patients for upper sternotomy AVR How to select patients for TAX AVR Click to Join   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*